ReDoc Software, Inc.

ReDoc Software, Inc. provides specialized documentation solutions for rehabilitation professionals through a comprehensive web-based platform, enhancing communication and compliance for healthcare providers. Founded in 1995 in Brentwood, US, ReDoc Software, Inc. offers streamlined documentation solutions for the rehabilitation sector.

The company was acquired by Net Health Systems in June 2014, but no details of its previous funding rounds or funding activities are available. The company's total funding raised is USD 0. 75 mn. ReDoc Software, Inc.

specializes in comprehensive documentation solutions tailored for rehabilitation professionals. Their flagship offering is a web-based platform that facilitates the creation, management, and storage of therapy documentation, improving communication among healthcare providers, patients, and insurance companies. The platform includes customizable templates, secure cloud storage, and integration with existing healthcare systems, addressing challenges in the rehabilitation sector such as compliance and inefficiency. Their client base primarily consists of rehabilitation clinics and therapists across North America and Europe, with localized support for specific market needs.

The revenue model of ReDoc Software, Inc. is based on subscription services, allowing clients to access their documentation platform through annual or monthly agreements. Clients benefit from updates and customer support as part of their subscriptions. The company may also offer tiered pricing plans to accommodate practices of various sizes.

Revenue comes from direct client subscriptions and potential partnerships with healthcare organizations requiring integrated documentation solutions, ensuring a stable income stream in the rehabilitation sector. ReDoc Software, Inc. plans to utilize its recent funding from June 2014 to enhance its product offerings and expand into new markets, although specific details about upcoming product launches or geographic regions targeted for expansion are not disclosed at this time.